Angel News

Angel News

Back to Homepage

5th March 2019

AdoRx collaborates with Johnson & Johnson Innovation

AdoRx Therapeutics, a UK based drug discovery company, has announced that it has entered into a strategic collaboration with Johnson & Johnson Innovation LLC* and the Lung Cancer Initiative at Johnson & Johnson to develop novel therapeutics for the treatment of lung cancer. 


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage